Atomoxetine in comorbid ADHD/PTSD: A randomized, placebo controlled, pilot, and feasibility study

MLA

Zhewu Wang, et al. “Atomoxetine in Comorbid ADHD/PTSD: A Randomized, Placebo Controlled, Pilot, and Feasibility Study.” Depression and Anxiety, vol. 39, Mar. 2022, pp. 286–95. EBSCOhost, https://doi.org/10.1002/da.23248.

APA

Zhewu Wang, Zachary D. Zuschlag, Ursula S. Myers, & Mark Hamner. (2022). Atomoxetine in comorbid ADHD/PTSD: A randomized, placebo controlled, pilot, and feasibility study. Depression and Anxiety, 39, 286–295. https://doi.org/10.1002/da.23248

Chicago

Zhewu Wang, Zachary D. Zuschlag, Ursula S. Myers, and Mark Hamner. 2022. “Atomoxetine in Comorbid ADHD/PTSD: A Randomized, Placebo Controlled, Pilot, and Feasibility Study.” Depression and Anxiety 39 (March): 286–95. doi:10.1002/da.23248.